跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
CEFTRIAXONE-AFT POWDER FOR INJECTION 2G/VIAL
Approved
THERAPEUTIC
CEFTRIAXONE-AFT POWDER FOR INJECTION 2G/VIAL
QILU PHARMACEUTICAL CO LTD - CHINAQILU ANTIBIOTICS PHARMACEUTICAL CO., LTD. (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
Apr 11, 2017
Approval ID
65d84ce334868c25
Company
QILU PHARMACEUTICAL CO LTD - CHINAQILU ANTIBIOTICS PHARMACEUTICAL CO., LTD. (CHINA)
Type
Therapeutic
Approval Details
Approval Id
65d84ce334868c25
Drug Name
CEFTRIAXONE-AFT POWDER FOR INJECTION 2G/VIAL
Product Name
CEFTRIAXONE-AFT POWDER FOR INJECTION 2G/VIAL
Approval Number
SIN15208P
Approval Date
2017-04-11
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01DD04
Atc Item Name
ceftriaxone
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
CEFTRIAXONE SODIUM 2.159g eqv to CEFTRIAXONE BASE
2g/vial
CEFTRIAXONE SODIUM 2.159 G EQV TO CEFTRIAXONE BASE
2 G/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 11, 2017
Approval ID
65d84ce334868c25
Type
Therapeutic
Back to HSA Approvals
CEFTRIAXONE-AFT POWDER FOR INJECTION 2G/VIAL - HSA Drug Approval Details
